Skip to content

Clinical trials

Postoperative Complications trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Postoperative Complications Country / region: Belgium Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20113
20142
20171
20181
20193
20201
20212
20221
20231
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Terminated1
Unknown status1
Withdrawn1
Suspended1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universitaire Ziekenhuizen KU Leuven3
AZ Sint-Jan AV2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2
Zealand Pharma2
Abbott Medical Devices1
Assistance Publique - Hôpitaux de Paris1
Astes1
Centre Hospitalier Universitaire de Liege1
Erasme University Hospital1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Postoperative Complications23
Digestive System Diseases2
Frailty2
Gastrointestinal Diseases2
Intestinal Diseases2
Malabsorption Syndromes2
Pathologic Processes2
Postoperative Pain2
Short Bowel Syndrome2
Airway Obstruction1

Trials

Showing 51 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.